The History and Physical in Cancer Care: A Primer for the Oncology Advanced Practitioner

Rosenzweig, Margaret; Gardner, Diane L.; Griffith, Brenda

doi:10.6004/jadpro.2014.5.4.3

Cited by 5 publications

(4 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The past medical history of the patient is considered important and has to be taken into account not only by the clinician, but also by the radiologist. A standardized checklist, primarily filled out by the patient, and discussed with the radiologist, is considered advisable [ 14 ]. The information that should be available for example includes recent trauma [ 15 , 16 ], anticoagulation [ 17 ], and a history of previous surgery or of radiation therapy [ 18 – 20 ].…”

Section: Discussionmentioning

confidence: 99%

Soft tissue tumor imaging in adults: European Society of Musculoskeletal Radiology-Guidelines 2023—overview, and primary local imaging: how and where?

Noebauer-Huhmann,

Vanhoenacker,

Vilanova

et al. 2023

Eur Radiol

View full text Add to dashboard Cite

Objectives Early, accurate diagnosis is crucial for the prognosis of patients with soft tissue sarcomas. To this end, standardization of imaging algorithms, technical requirements, and reporting is therefore a prerequisite. Since the first European Society of Musculoskeletal Radiology (ESSR) consensus in 2015, technical achievements, further insights into specific entities, and the revised WHO-classification (2020) and AJCC staging system (2017) made an update necessary. The guidelines are intended to support radiologists in their decision-making and contribute to interdisciplinary tumor board discussions. Materials and methods A validated Delphi method based on peer-reviewed literature was used to derive consensus among a panel of 46 specialized musculoskeletal radiologists from 12 European countries. Statements were scored online by level of agreement (0 to 10) during two iterative rounds. Either “group consensus,” “group agreement,” or “lack of agreement” was achieved. Results Eight sections were defined that finally contained 145 statements with comments. Overall, group consensus was reached in 95.9%, and group agreement in 4.1%. This communication contains the first part consisting of the imaging algorithm for suspected soft tissue tumors, methods for local imaging, and the role of tumor centers. Conclusion Ultrasound represents the initial triage imaging modality for accessible and small tumors. MRI is the modality of choice for the characterization and local staging of most soft tissue tumors. CT is indicated in special situations. In suspicious or likely malignant tumors, a specialist tumor center should be contacted for referral or teleradiologic second opinion. This should be done before performing a biopsy, without exception. Clinical relevance The updated ESSR soft tissue tumor imaging guidelines aim to provide best practice expert consensus for standardized imaging, to support radiologists in their decision-making, and to improve examination comparability both in individual patients and in future studies on individualized strategies. Key Points • Ultrasound remains the best initial triage imaging modality for accessible and small suspected soft tissue tumors. • MRI is the modality of choice for the characterization and local staging of soft tissue tumors in most cases; CT is indicated in special situations. Suspicious or likely malignant tumors should undergo biopsy. • In patients with large, indeterminate or suspicious tumors, a tumor reference center should be contacted for referral or teleradiologic second opinion; this must be done before a biopsy.

show abstract

Section: Discussionmentioning

confidence: 99%

Soft tissue tumor imaging in adults: European Society of Musculoskeletal Radiology-Guidelines 2023—overview, and primary local imaging: how and where?

Noebauer-Huhmann,

Vanhoenacker,

Vilanova

et al. 2023

Eur Radiol

View full text Add to dashboard Cite

show abstract

“…. ); neck (palpate the cervical lymph nodes); back (palpate the spine and muscles) and various systematic examinations of the individual system [133,134] Medical history Personal medical history, past surgical history, family medical history, and social history. [135] Cancer screening test Fecal occult blood test (FOBT), Cologuard, Pap smear [136][137][138][139]…”

Section: Traditional Medical Testing (Non-ctc-related)mentioning

confidence: 99%

“…This includes noteworthy deviations like fluctuations in weight and blood pressure. Such data can be shared with medical professionals, enabling them to accurately assess the patient's condition and make necessary adjustments to their treatment plans [133,134].…”

Section: Patient's Physiological Parametersmentioning

confidence: 99%

Recent Progress in Enhanced Cancer Diagnosis, Prognosis, and Monitoring Using a Combined Analysis of the Number of Circulating Tumor Cells (CTCs) and Other Clinical Parameters

Nguyen,

Huang,

Chu

et al. 2023

Cancers

View full text Add to dashboard Cite

Analysis of circulating tumor cells (CTCs) holds promise to diagnose cancer or monitor its development. Among the methods, counting CTC numbers in blood samples could be the simplest way to implement it. Nevertheless, its clinical utility has not yet been fully accepted. The reasons could be due to the rarity and heterogeneity of CTCs in blood samples that could lead to misleading results from assays only based on single CTC counts. To address this issue, a feasible direction is to combine the CTC counts with other clinical data for analysis. Recent studies have demonstrated the use of this new strategy for early detection and prognosis evaluation of cancers, or even for the distinguishment of cancers with different stages. Overall, this approach could pave a new path to improve the technical problems in the clinical applications of CTC counting techniques. In this review, the information relevant to CTCs, including their characteristics, clinical use of CTC counting, and technologies for CTC enrichment, were first introduced. This was followed by discussing the challenges and new perspectives of CTC counting techniques for clinical applications. Finally, the advantages and the recent progress in combining CTC counts with other clinical parameters for clinical applications have been discussed.

show abstract

“…1 Clinical examination is an essential component of disease evaluation, assessing clinical response and toxicity and complements imaging findings. 2 Minimisation of Coronavirus disease (COVID-19) infection risks necessitated cancellation or rescheduling of elective outpatient follow-ups. Moreover, redeployment of oncology staff to COVID-19 workflow has also contributed towards curtailment of cancer care.…”

Section: Introductionmentioning

confidence: 99%

Triaging and adaptations of surveillance of cancer services in the COVID pandemic

Lewis

Gurram

Velu³

et al. 2020

J Radiother Pract

View full text Add to dashboard Cite

Introduction: Coronavirus disease (COVID-19) has significantly challenged the access to cancer care and follow-up for a patient with cancer. Methods: Based on published literature and our experiences, it is reasonable to presume that clinical examination and follow-up visits have been significantly curtailed worldwide in order to adhere to the new norms during the pandemic. Although telephonic and telemedicine consultations may help bridge a few gaps, completely dispensing with in-person consultation has its challenges, especially in low middle-income countries. Telephonic consultations could facilitate triaging of ambulatory cancer patients and allocation of face-to-face consultations for high priority patients. Conclusions: We propose a telephonic consultation-based triaging approach for ambulatory cancer patients in order to identify those needing in-hospital consultations.

show abstract

The History and Physical in Cancer Care: A Primer for the Oncology Advanced Practitioner

Abstract: Advanced practitioners (APs) specializing in cancer care will most like-

Cited by 5 publications

References 15 publications

Soft tissue tumor imaging in adults: European Society of Musculoskeletal Radiology-Guidelines 2023—overview, and primary local imaging: how and where?

Soft tissue tumor imaging in adults: European Society of Musculoskeletal Radiology-Guidelines 2023—overview, and primary local imaging: how and where?

Recent Progress in Enhanced Cancer Diagnosis, Prognosis, and Monitoring Using a Combined Analysis of the Number of Circulating Tumor Cells (CTCs) and Other Clinical Parameters

Triaging and adaptations of surveillance of cancer services in the COVID pandemic

Contact Info

Product

Resources

About